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Zusammenfassung 
Myxobakterien sind Gram-negative Bodenbakterien, die sich durch ihren komplexen 
Lebenszyklus auszeichnen. Bei Nährstoffmangel bilden sie multizelluläre Aggregate, die  
als Fruchtkörper bezeichnet werden, und in denen sich die Zellen zu Myxosporen 
differenzieren, die gegen Hitze und Austrocknung resistent sind. Die biochemischen 
Veränderungen während dieses Vorgangs sind größtenteils unbekannt. 
Die vorliegende Arbeit befasst sich mit der Analyse des Lipidoms im Modellorganismus 
Myxococcus xanthus, vor allem während der Entwicklung von Fruchtkörpern. Neben 
tieferen Einblicken in die myxobakterielle Fettsäurebiosynthese zeigten die 
Untersuchungen eine vermehrte Bildung von ungewöhnlichen verzweigtkettigen 
Etherlipiden unter Entwicklungsbedingungen, ebenso wie das Auftreten von Vesikeln, die 
hauptsächlich aus Triacylglycerol bestehen. Eine weitere Beobachtung war die Aktivierung 
der -Oxidation von Fettsäuren, bei der eine Familie von stereospezifischen Fettsäure-
-Hydroxylasen eine entscheidende Rolle spielt. Außerdem ergaben sich Hinweise auf 
das Vorkommen von Sphingolipiden, was für Bakterien ebenfalls ungewöhnlich ist. 
Die gewonnenen Erkenntnisse sollen dazu dienen, den Lipidstoffwechsel und auch das 
komplexe Regulationsnetzwerk, das dem Lebenszyklus der Myxobakterien zugrunde liegt, 
besser zu verstehen. Enzyme des bakteriellen Lipidstoffwechsels stellen interessante 
Targets für die Entwicklung neuer Antibiotika dar, und die Stoffwechselwege der 
Myxobakterien sind möglicherweise auf pathogene Bakterien übertragbar. Außerdem 
greifen die Biosynthesewege mehrerer myxobakterieller Sekundärstoffe auf den 
Lipidstoffwechsel zurück, so dass die erhaltenen Daten auch beitragen werden zum 
Verständnis des Zusammenspiels von Primär- und Sekundärstoffwechsel, das 
vielversprechende Leitstrukturen für die pharmazeutische und landwirtschaftliche Nutzung 
hervorbringt. 
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Abstract 
Myxobacteria are Gram-negative soil bacteria with a complex life cycle. In response to 
starvation, they form multicellular aggregates named fruiting bodies, in which the cells 
differentiate into heat- and desiccation-resistant myxospores. The biochemical changes 
during this process are mostly unknown. 
In this study, the lipidome of the model organism Myxococcus xanthus has been analyzed, 
in particular during the time course of fruiting body development. Besides deeper insights 
into fatty acid biosynthesis in these organisms, the analyses revealed an accumulation of 
unusual branched-chain ether lipids and the formation of triacylglycerol vesicles under 
developmental conditions. Furthermore, an activation of fatty acid -oxidation could be 
observed, and a family of stereospecific fatty acid -hydroxylases involved in this process 
has been identified. Evidence is presented that myxobacteria contain sphingolipids as 
another unusual structural feature in the lipidome. 
These data will help to shed more light into the lipid metabolism and the mechanisms 
governing the complex life cycle of myxobacteria. Enzymes of the bacterial lipid 
metabolism are interesting targets for the development of antibacterial agents, and the 
results gained from myxobacteria may give helpful hints to find homologous enzymes in 
pathogenic bacteria. Furthermore, the biosynthesis of several myxobacterial secondary 
metabolites relies on certain reactions from lipid metabolism. The data presented here will 
help to understand how primary and secondary metabolism work together to produce 
promising lead structures for pharmaceutical and agricultural use. 
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Introduction 
1. Introduction 
1.1. Myxobacteria and their outstanding life cycle 
Myxobacteria are Gram-negative, obligate aerobic bacteria constituting the order 
Myxococcales in the Delta group of Proteobacteria. This order is again subdivided into the 
three suborders Cystobacterineae, Sorangiineae and Nannocystineae (115), although 
some sources define the latter two as one suborder Sorangineae (19,102). Myxobacteria 
are typically rod-shaped, with a length of 3-15 µm and a diameter of 0.6-1.2 µm (101). 
Whereas most myxobacterial species live in normal soil, several strains have been 
isolated from more special habitats (115) such as marine (45) or halophilic (46) as well as 
acidic or alkaline environments (101). Myxobacteria are known for some outstanding 
biological features: On solid surfaces, they form swarms to gain access to nutrients 
(53,59), which are usually other microorganisms (25). Most myxobacteria secrete digestive 
enzymes to kill these microorganisms (124) and to decompose the released proteins, 
lipids and nucleic acids. In contrast to this, some members of the Sorangiineae, especially 
Sorangium, are cellulose degraders, enabling them to grow on cellulose in the presence of 
inorganic nitrogen sources (115). 
Under starvation conditions, myxobacteria form multicellular aggregates called fruiting 
bodies (Figure 1), in which the cells differentiate into heat- and desiccation-resistant 
myxospores which are able to retransform into normal vegetative cells when nutrients 
become avaliable again (26). This type of multicellular organization is extraordinary among 
prokaryotes, and the morphology of fruiting bodies can vary from spheres to more complex 
tree-like structures (115). In contrast to this, myxobacterial cells grow independently in 
liquid media. Myxobacterial genomes are very large, for instance, the model organism 
Myxococcus xanthus DK1622 has a genome size of 9.1 Mbp (35), and the genome of 
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Sorangium cellulosum So ce56 (13 Mbp) is the largest bacterial genome known so far 
(113). Furthermore, myxobacteria are a source of natural products with promising lead 
structures for pharmaceutical and agricultural applications (9,34), the most prominent 
example being the tubuline-stabilizing epothilones from S. cellulosum (11), whose 
derivatives are predicted a high significance in cancer therapy because of their activity 
against multidrug resistant solid tumors (105). 
The enormous size of myxobacterial genomes partially results from lineage-specific gene 
duplications (35,108,113), and in particular, genes encoding proteins with regulatory 
functions such as kinases/phosphatases, 54 enhancer-binding proteins and 
extracytoplasmic -factors as well as two-component signal transduction systems are 
affected by these duplications (35,108,113). This shows that the myxobacterial lifestyle, 
including social behavior, gliding motility and fruiting body development (53) as well as 
predation (6) and even secondary metabolism (28,100), is governed by a large complex 
regulatory network, driven by chemotaxis (145) and intercellular signals (54,116). During 
the last decades, more and more insights were gained how these different aspects of the 
myxobacterial lifestyle are connected to each other, e.g. the coupling of motility and 
development (53) or the activities of certain secondary metabolites in the context of 
development (86,98). The following chapter will give a more detailed description of 
myxobacterial development, leading to the considerations about the role of primary 
metabolism for fruiting body formation and sporulation. 
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Figure 1. Fruiting body formation of Myxococcus xanthus DK1622. 
Scanning electon micrographs of the developmental time course in submerged culture obtained 
by Kuner and Kaiser (64). Reprinted with permission. 
Copyright © 1982, American Society for Microbiology 
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1.2. Myxococcus xanthus – Motility and fruiting body development 
The principles of myxobacterial motility and fruiting body development have been 
extensively studied in the model organism Myxococcus xanthus (53,54,116), as 
techniques for cultivation and subsequent induction of fruiting body formation have been 
established for this organism (13,43,63,64). Most experiments have been done with strain 
DK1622, which is fully motile on solid surfaces and grows dispersely in liquid culture (52). 
Furthermore, its genome has been sequenced (35), and protocols for targeted genetic 
manipulations are available (36,49), including recently developed autonomously replicating 
plasmids (144). Another model organism among myxobacteria which is worth mentioning 
and whose lipidome was also subject of the present study is Stigmatella aurantiaca 
DW4/3-1 (90,98). 
Two engines have been described for the motility of M. xanthus (53), referred to as the A-
engine and the S-engine. The A-engine (A for adventurous) accounts for the motility of 
single cells, and its underlying mechanism is supposed to be the production of slime at the 
cell pole pointing to the opposite direction of movement. The S-engine (S for social) is 
constituted by type IV pili which adhere to neighboring cells and thus enable movement 
towards these cells by retraction of the pilus. Mutants deficient in both motility engines are 
nonmotile and are also deficient in fruiting body formation (53). 
Formation of fruiting bodies and subsequent differentiation of cells into myxospores (the 
whole process is referred to as myxobacterial development) is a highly complex 
procedure. Regarding the outward appearance, aggregates are visible 8-12 h after 
entering the starvation state, and fruiting body morphogenesis with around 105 cells per 
fruiting body is completed after 24-48 h (116) and followed by spore maturation. During 
formation of the fruiting body, some of the cells are killed by autolysis (26), which has been 
postulated to be a sacrifice to ensure survival of the colony, e.g. by improving the protein 
4 
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biosynthesis capacity of the remaining cells, as the gene expression pattern changes 
severely during development (47). However, more recent comparisons have shown that 
the extent of autolysis varies between strains (145), and the requirement for sacrifice has 
been put into question by the finding that development is also induced by a step-down in 
nutrition rather than by sudden starvation (5). Most of the cells in the fruiting bodies 
transform into myxospores, which differ from vegetative cells by their round (M. xanthus) 
or short rod-shaped (S. aurantiaca) morphology (132), whereas 10 % of cells does not 
enter fruiting bodies but retains its rod shape and differentiates into so-called peripheral 
rods (see also Chapter 2.5), which are able to utilize low nutrient levels and are supposed 
to enable a faster re-formation of a swarm when nutrients become available again (92), in 
contrast to myxospores which have to re-differentiate into vegetative cells. Myxospores, 
however, are more resistant to environmental stress (123) and can survive long-term 
starvation (115). The above mentioned morphological transformation of a vegetative cell 
into a myxospore must be accompanied by biochemical changes in the cell, which is 
evident regarding the formation of a thick spore cortex and coat (48,125) and the 
accumulation of trehalose in myxospores (84). To obtain more information about the 
metabolic processes occurring during sporulation, alternatives to starvation on solid 
surfaces have been established for large-scale sporulation, such as glycerol-induced 
sporulation (27) and sporulation in starvation buffer (109). However, these spores differ 
from fruiting body spores already from the morphological point of view, e.g. glycerol spores 
do not have the typical spore coat, as the sporulation-specific protein S is not accumulated 
in glycerol spores (47), so the spores obtained by these practical simplifications are not 
fully comparable to fruiting body spores. 
Several efforts have been made to characterize the mechanism by which myxobacterial 
cells coordinate the formation of fruiting bodies and sporulation. Information was gained by 
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the analysis of mutants unable to accomplish development. Among these mutants, five 
complementation groups have been identified (22,38), which are deficient in the formation 
of fruiting bodies and/or spores but whose deficiency can be overcome by co-development 
with wild-type cells or mutants from a different complementation group. Because of this 
observation, the presence of intercellular signals (A- to E-signal) was postulated, and the 
gene loci in which the respective mutations had occurred were designated asg, bsg, csg, 
dsg and esg (22,38). 
A-signaling turned out to be a quorum sensing mechanism, relying on certain amino acids 
which are released at micromolar concentrations by starving cells (66) probably in the 
context of stringent response (120). The concentration of these amino acids directly 
correlates with cell density, and this enables Myxococcus cells to sense if there are 
sufficient cells for fruiting body formation nearby. On the other hand, amino acid 
concentrations supporting slow growth prevent induction of the developmental program. 
Thus, A-signaling is assumed to play a crucial role for the decision for or against 
development (54), which is supported by the fact that the release of A-signal occurs at a 
very early time point, usually 2 h after entering nutrient limitation conditions. 
C-signaling is mediated by cell-to-cell contact, and the CsgA protein has been shown to be 
involved in this type of intercellular communication (117). CsgA is a 25 kDa cell surface 
protein (70) which is transformed into its 17 kDa active form by cleavage of the N-terminus 
via the secreted protease PopC (107). However, an overproduction of SocA, which is 
highly similar to CsgA (51 % similarity on the amino acid level), restores development (68). 
Both CsgA in its native 25 kDa form and SocA show similarities to short-chain alcohol 
dehydrogenases, and lysophosphatidylethanolamine has been identified as a substrate for 
SocA (3). These findings suggest that the C-signal is not the CsgA protein itself, but 
maybe the product of a reaction catalyzed by CsgA and/or SocA. 
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Figure 2. The first two biochemical steps of the branched-chain amino acid 
degradation pathway. 
Valine, leucine and isoleucine are transaminated and then oxidatively decarboxylated to CoA 
esters. 
The principles of B- and D-signaling have not been fully elucidated up till now. Although 
the bsg and dsg loci have been identified, it is still unclear whether signaling molecules or 
other mechanisms play a role (54). 
The esg locus turned out to constitute the genes encoding the subunits of the branched-
chain keto acid dehydrogenase Bkd (126), which is a key enzyme in the degradation 
pathway of branched-chain amino acids (82). Valine, leucine and isoleucine are 
transformed into 2-oxo acids by a transaminase (IlvE), and the following step is an 
oxidative decarboxylation catalyzed by Bkd (96), resulting in the coenzyme A (CoA) 
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thioesters isobutyryl-CoA, isovaleryl-CoA and 2-methylbutyryl-CoA, respectively (Figure 2). 
For a better understanding of the connections between this pathway and myxobacterial 
development, it is necessary to give an introduction about bacterial fatty acid biosynthesis. 
1.3. Biosynthesis of fatty acids in myxobacteria 
Fatty acid biosynthesis in bacteria is carried out via a group of highly conserved proteins 
(73,106,141). In contrast to the type I fatty acid synthase in most eukaryotes, which is a 
huge multifunctional enzyme, the type II fatty acid synthase system consists of several 
single proteins, each one catalyzing one step of the biosynthesis (Figure 3). The overall 
mechanism is the growth of an acyl chain bound to an acyl carrier protein (ACP). 
-ketoacyl-ACP synthases (KAS, syn. 3-oxoacyl-ACP synthases) are responsible for 
elongation of the fatty acyl chain by two carbon atoms, and the underlying reaction is a 
Claisen-like condensation of a thioester with the active methylene group of malonyl-ACP, 
the latter resulting from carboxylation of acetyl-CoA and transfer of the malonyl residue to 
an ACP. In the first occurring reaction, which is catalyzed by KAS III (FabH), the thioester 
is a CoA ester, usually acetyl-CoA, giving rise to straight-chain fatty acids (SCFAs). 
One type of fatty acid diversity often encountered in bacteria is caused by variation of the 
starter unit, i.e. the substitution of acetyl-CoA by other CoA esters. For instance, the use of 
propionyl-CoA results in an SCFA with an odd number of carbon atoms (42), whereas 
butyryl-CoA would not make a difference to acetyl-CoA at first sight. However, an 
interesting variation are branched-chain fatty acids (BCFAs), which are formed by 
employing isobutyryl-CoA, isovaleryl-CoA and 2-methylbutyryl-CoA as starter units of fatty 
acid biosynthesis (55). The substrate specificity of FabH is crucial for selection of the 
starter unit (15,40), and crystal structure data gave valuable information about correlations 
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Figure 3. Fatty acid biosynthesis in bacteria. 
The elongation unit malonyl-ACP is condensed with the starter CoA ester by FabH. The 
resulting 3-oxoacyl-ACP is then reduced in an NADPH-dependent reaction to a 
3-hydroxyacyl-ACP by FabG, dehydrated by FabA or FabZ to a trans-2-enoyl-ACP, and the acyl 
chain is saturated by FabI. Subsequent codensations with further malonyl-ACP units are 
catalyzed by FabB or FabF. 
For a complete list of gene and protein designations, see 4.2. 
between substrate specificity and the size and structure of the acyl-CoA primer binding 
pocket of FabH enzymes (99,112). 
The fatty acid profiles of myxobacteria (20,138) mainly consist of BCFAs, namely iso-fatty 
acids with an odd total number of carbons (iso-odd fatty acids). This type of fatty acid is 
biosynthesized by using isovaleryl-CoA as a starter unit (7,16,55), and as this metabolite is 
also an intermediate in leucine degradation, the pathways of branched-chain amino acid 
degradation and BCFA biosynthesis are directly coupled. The formation of iso-odd fatty 
acids is not only dependent on the substrate specificity of FabH, but also on precursor 
supply, for which Bkd is one of the essential enzymes. Consequently, myxobacterial 
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strains with a mutation in their esg locus (more appropriately: bkd locus) should be 
deficient in iso-fatty acid biosynthesis. However, in contrast to the bkd mutants of 
streptomycetes (17) or Bacillus (143), bkd mutants of Myxococcus xanthus and 
Stigmatella aurantiaca show a reduction, but not a total loss of iso-odd fatty acids, 
indicating that an alternative source of isovaleryl-CoA must be present. By feeding 
experiments, the existence of a shunt pathway branching from the mevalonate pathway 
has been proven (75,76). 
Concerning the strategy of feeding experiments in this context, it has to be mentioned that 
isovaleryl-CoA (as well as isobutyryl-CoA and 2-methylbutyryl-CoA) also serves as a 
starter unit for polyketide synthesis, as shown for myxothiazol (119,128) or myxalamid 
(118), so these CoA ester primers connect primary and secondary metabolism. Thus, 
feeding of labeled substrates which are channeled into the isovaleryl-CoA pool will result in 
labeling of not only iso-odd fatty acids, but also compounds derived from iso-odd fatty 
acids and secondary metabolites originating from isovaleryl-CoA. On the one hand, this 
metabolic connection helps to distinguish n-odd fatty acids from iso-odd fatty acids during 
mass spectrometrical analysis, as the fragmentation patterns are identical in most cases 
but iso-odd fatty acids can be specifically labeled with leucine (see also 
Chapters 2.2 and 2.3). On the other hand, the different biochemical pathways leading to 
isovaleryl-CoA may be elucidated via analysis of the labeling pattern of iso-odd fatty acids 
and/or the appropriate secondary metabolites. The interface between primary and 
secondary metabolism is even extended by the shunt pathway mentioned above. The 
importance of different precursors on the mevalonate pathway can be determined by the 
analysis of secondary metabolites whose biosynthesis relies on the formation of isoprenoid 
structures. The most appropriate substance to be analyzed in this context is the degraded 
sesquiterpene geosmin (33), as it occurs in several myxobacterial strains and its 
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biosynthesis in myxobacteria has been elucidated (21,127). Other examples for natural 
products with isoprenoid structures in myxobacteria are aurachin (110) and leupyrrin 
(8,10). 
1.4. Aims of the present study 
The present work focuses on the lipidome of Myxococcus xanthus DK1622, with some 
comparative studies regarding other myxobacterial species, in particular 
Stigmatella aurantiaca DW4/3-1. The central aim was a further characterization of the 
biochemical changes occurring during development of myxobacterial cells. As mentioned 
above, trehalose (84) and protein S (48) accumulate in myxospores and can therefore be 
regarded as biomarkers for sporulation. The term "biomarker" in general refers to a 
characteristic which serves as an indicator of biological processes and is widely used in 
medicine (134), e.g. for substances in body fluids whose amount gives valuable 
information about the progress of a disease. Finding biomarkers is also an interesting field 
in microbiology, for measuring biomarker levels is a powerful tool to assess the 
physiological state of the cell without the need for time-consuming purely microbiological 
methods such as colony counting (62). Since finding and measuring biomarkers in 
microbiology usually implies transcriptomics (32,49,62), it would be interesting to find low 
molecular biomarkers, which may be more suitable for routine analysis. 
In the context of myxobacterial development, substances which increase specifically 
during development and therefore can be used to monitor the progress of development 
can be regarded as biomarkers. For this reason, characterization of biochemical changes 
during development is directly linked to finding additional biomarkers for development. 
However, it has to be mentioned that the observation that a metabolite increases during 
development does not yield any information about whether the production of the 
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metabolite is a requirement or a consequence of development or if the metabolite is just a 
by-product of a developmentally upregulated reaction. If the biomarker is a protein or if the 
biosynthesis of the metabolite is known, inactivation of the responsible genes and 
phenotypical analysis of the resulting mutants will help to clarify the physiological role. In 
other cases, genes involved in the biosynthesis first have to be found.  
During differentiation of the vegetative cell into a myxospore, the cell envelope undergoes 
a dramatical change regarding the shift from long rod-shaped to spherical or short rod-
shaped morphology (132) and the formation of the spore coat (48). As a significant part of 
the cell envelope consists of membrane phospholipids, it is evident that the lipidome 
changes during sporulation and that additional biomarkers can be most likely found among 
cellular lipids. These considerations led to a more detailed characterization of the overall 
lipidome, i.e. the different classes of lipids. It has been shown that 
phosphatidylethanolamine (PE) is the major lipid class in M. xanthus (95), but there were 
no reports about the molecular species and the fatty acid composition of the distinct lipid 
classes. Consequently, there was no knowledge about shifts from one lipid class to 
another during development, nor about alterations of the molecular composition within one 
lipid class. 
The connection between lipid metabolism and the postulated E-signal (see 1.3) brought up 
the aim to shed more light into the nature of the E-signal and the underlying mechanisms, 
which included gaining further insights into myxobacterial fatty acid biosynthesis via 
feeding experiments and analysis of mutants. 
Finally, the generation of fatty acid diversity by structural modifications after the 
biosynthesis of the actual long-chain acyl residues was analyzed. Large amounts of fatty 
acids with double bonds at the unusual positions 5 and 11 can be found in myxobacteria, 
with the otherwise rare fatty acid 16:111 (16:15c) being the most abundant straight-chain 
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fatty acid in M. xanthus and S. aurantiaca. Besides double bonds, hydroxyl groups at the 
2- or 3-position of fatty acids have been described (29). It was unknown how double bonds 
and hydroxyl groups are introduced into the fatty acyl chains in myxobacteria, and if or 
how these fatty acid families play a role in the myxobacterial life cycle. 
To summarize, the overall aim of the present study was to find lipid biomarkers and other 
metabolites which are important in the context of the myxobacterial life cycle and to 
elucidate their biosynthetic pathways as well as their relevance for fruiting body formation 
and sporulation.  
13 
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2. Publications of the results 
2.1. Straight-chain fatty acids are dispensable in the myxobacterium 
Myxococcus xanthus for vegetative growth and fruiting body 
formation 
Helge B. Bode*, Michael W. Ring, Dale Kaiser, Anna C. David, 
Reiner M. Kroppenstedt and Gertrud Schwär 
Journal of Bacteriology 
Vol. 188 (15), pp. 5632-4, Aug. 2006 
Copyright © 2006, American Society for Microbiology. All Rights Reserved. 
Abstract 
Inactivation of the MXAN_0853 gene blocked the production in Myxococcus xanthus of 
straight-chain fatty acids which otherwise represent 30% of total fatty acids. Despite this 
drastic change in the fatty acid profile, no change in phenotype could be observed, which 
contrasts with previous interpretations of the role of straight-chain fatty acids in the 
organism’s development. 
 
 
The full text of this article is available online at 
http://jb.asm.org/cgi/content/full/188/15/5632 
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2.2. 3-Hydroxy-3-methylglutaryl-coenzyme A (CoA) synthase is 
involved in the biosynthesis of isovaleryl-CoA in the 
myxobacterium Myxococcus xanthus during fruiting body 
formation 
Helge B. Bode*, Michael W. Ring, Gertrud Schwär, Reiner M. Kroppenstedt, 
Dale Kaiser and Rolf Müller* 
Journal of Bacteriology 
Vol. 188 (18), pp. 6524-8, Sept. 2006 
Copyright © 2006, American Society for Microbiology. All Rights Reserved. 
Abstract 
Isovaleryl-coenzyme A (IV-CoA) is the starting unit for some secondary metabolites and 
iso-odd fatty acids in several bacteria. According to textbook biochemistry, IV-CoA is 
derived from leucine degradation, but recently an alternative pathway that branches from 
the well-known mevalonate-dependent isoprenoid biosynthesis has been described for 
myxobacteria. A double mutant was constructed in Myxococcus xanthus by deletion of 
genes involved in leucine degradation and disruption of mvaS encoding the 3-hydroxy-3-
methylglutarylcoenzyme A synthase. A dramatic decrease of IV-CoA-derived iso-odd fatty 
acids was observed for the mutant, confirming mvaS to be involved in the alternative 
pathway. Additional quantitative real-time reverse transcription-PCR experiments indicated 
that mvaS is transcriptionally regulated by isovalerate. Furthermore, feeding studies 
employing an intermediate specific for the alternative pathway revealed that this pathway 
is induced during fruiting body formation, which presumably increases the amount of IV-
CoA available when leucine is limited. 
 
 
The full text of this article is available online at 
http://jb.asm.org/cgi/content/full/188/18/6524 
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2.3. Novel iso-branched ether lipids as specific markers of 
developmental sporulation in the myxobacterium Myxococcus 
xanthus 
Michael W. Ring, Gertrud Schwär, Verena Thiel, Jeroen S. Dickschat, 
Reiner M. Kroppenstedt, Stefan Schulz and Helge B. Bode* 
Journal of Biological Chemistry 
Vol. 281 (48), pp. 36691-700, December 1, 2006 
© 2006 by The American Society for Biochemistry and Molecular Biology, Inc. 
Abstract 
Iso-fatty acids (FAs) are the dominant FA family in all myxobacteria analyzed. 
Furthermore, it was postulated that iso-FAs or compounds derived thereof are involved in 
fruiting body formation in Myxococcus xanthus, since mutants with a reduced level of iso-
FA due to a reduced level of the precursor isovaleryl-CoA, are delayed in aggregation and 
produce only few myxospores. To elucidate the function of iso-FAs and their corresponding 
lipids we have analyzed the developmental phenotype of mutants having different levels of 
iso-FAs resulting in a clear correlation between the amount of iso-FAs and the delay of 
aggregation and reduction in spore yield. Addition of either isovalerate or 
13-methyltetradecanoic acid resulted in restoration of the wild-type FA profile and normal 
development. Detailed analysis of the fatty acid (FA) profile during fruiting body formation 
in Myxococcus xanthus wild-type revealed the specific accumulation of 
13-methyltetradecanal and 1-O-13-methyltetradecylglycerol which were produced 
specifically in the myxospores and which are derived from 
1-O-(13-methyl-1-Z-tetradecenyl)-2-O-(13-methyltetradecanoyl)-glycero-
3-phosphatidylethanolamine (VEPE) and 1,2-di-(13-methyltetradecanoyl)-
3-(13-methyltetradecyl)glycerol (TG-1), respectively. The structures of these unusual ether 
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lipids have been determined by spectrometric methods and synthesis (for TG-1). Analysis 
of several mutants blocked at different stages of development indicated that the 
biosynthesis of TG-1 is developmentally regulated and that VEPE might be an intermediate 
in the TG-1 biosynthesis. Finally, addition of TG-1 to mutants blocked in the biosynthesis of 
isovaleryl-CoA could restore aggregation and sporulation emphasizing the important role of 
iso-branched lipids for myxobacterial development. 
 
 
The full text of this article is available online at 
http://www.jbc.org/cgi/content/full/281/48/36691 
 
20 
Publications 
2.4. Identification of additional players in the alternative biosynthesis 
pathway to isovaleryl-CoA in the myxobacterium Myxococcus 
xanthus 
Helge B. Bode, Michael W. Ring, Gertrud Schwär, Matthias O. Altmeyer, 
Carsten Kegler, Ivy R. Jose, Mitchell Singer and Rolf Müller* 
ChemBioChem – A European Journal of Chemical Biology 
Vol. 10 (1), pp. 128-140, January 5, 2009 
Copyright © 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim 
Abstract 
Isovaleryl-CoA (IV-CoA) is usually derived from the degradation of leucine by using the 
Bkd (branched-chain keto acid dehydrogenase) complex. We have previously identified an 
alternative pathway for IV-CoA formation in myxobacteria that branches from the well-
known mevalonate-dependent isoprenoid biosynthesis pathway. We identified 3-hydroxy-
3-methylglutaryl-CoA (HMG-CoA) synthase (MvaS) to be involved in this pathway in 
Myxococcus xanthus, which is induced in mutants with impaired leucine degradation (e.g., 
bkd-) or during myxobacterial fruiting-body formation. Here, we show that the proteins 
required for leucine degradation are also involved in the alternative IV-CoA biosynthesis 
pathway through the efficient catalysis of the reverse reactions. Moreover, we conducted a 
global gene-expression experiment and compared vegetative wild-type cells with bkd 
mutants, and identified a five-gene operon that is highly up-regulated in bkd mutants and 
contains mvaS and other genes that are directly involved in the alternative pathway. Based 
on our experiments, we assigned roles to the genes required for the formation of IV-CoA 
from HMG-CoA. Additionally, several genes involved in outer-membrane biosynthesis and 
a plethora of genes encoding regulatory proteins were decreased in expression levels in 
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the bkd- mutant; this explains the complex phenotype of bkd mutants including a lack of 
adhesion in developmental submerse culture. 
 
The full text of this article is available online at 
http://www3.interscience.wiley.com/journal/121431880/abstract 
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2.5.  Lipid body formation plays a central role in cell fate 
determination during developmental differentiation of 
Myxococcus xanthus 
Egbert Hoiczyk*, Michael W. Ring, Colleen A. McHugh, Gertrud Schwär, 
Edna Bode, Daniel Krug, Matthias O. Altmeyer, Jeff Zhiqiang Lu and 
Helge B. Bode* 
Molecular Microbiology 
Vol. 74 (2), pp. 497-517, Oct. 2009 
© 2009 The Authors 
Journal compilation © 2009 Blackwell Publishing Ltd 
Summary 
Cell differentiation is widespread during the development of multicellular organisms, but 
rarely observed in prokaryotes. One example of prokaryotic differentiation is the Gram-
negative bacterium Myxococcus xanthus. In response to starvation, this gliding bacterium 
initiates a complex developmental programme that results in the formation of spore-filled 
fruiting bodies. How the cells metabolically support the necessary complex cellular 
differentiation from rod-shaped vegetative cells into spherical spores is unknown. Here, we 
present evidence that intracellular lipid bodies provide the necessary metabolic fuel for the 
development of spores. Formed at the onset of starvation, these lipid bodies gradually 
disappear until they are completely used up by the time the cells have become mature 
spores. Moreover, it appears that lipid body formation in M. xanthus is an important initial 
step indicating cell fate during differentiation. Upon starvation, two subpopulations of cells 
occur: cells that form lipid bodies invariably develop into spores, while cells that do not 
form lipid bodies end up becoming peripheral rods, which are cells that lack signs of 
morphological differentiation and stay in a vegetative-like state. These data indicate that 
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lipid bodies not only fuel cellular differentiation but that their formation represents the first 
known morphological sign indicating cell fate during differentiation. 
 
The full text of this article is available online at 
http://www3.interscience.wiley.com/journal/122612846/abstract 
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2.6. Functional analysis of desaturases from the myxobacterium 
Myxococcus xanthus 
Michael W. Ring, Edna Bode, Gertrud Schwär and Helge B. Bode* 
FEMS Microbiology Letters 
Vol. 296 (1), pp. 124-130, Jul. 2009 
© 2009 Federation of European Microbiological Societies. 
Published by Blackwell Publishing Ltd. All rights reserved. 
Abstract 
The fatty acid profiles of myxobacteria contain fatty acid species with double bonds at the 
5 and 11 positions, the latter being rather unusual among bacteria. Despite this 
knowledge, the mechanism for introduction of these double bonds has never been 
described before in myxobacteria. Searches for candidate genes in the genome of the 
model organism Myxococcus xanthus revealed 16 genes which have been annotated as 
fatty acid desaturases. However, due to redundant substrate specificity, functional 
analyses of these enzymes by construction of inactivation mutants did not lead to the 
identification of their function or substrate specificity. Therefore, we elucidated the 
regioselectivity of the desaturation reactions by heterologous expression of eight 
desaturases from Myxococcus xanthus in Pseudomonas putida and thus could prove five 
of them to be indeed active as desaturases with three (MXAN_1742, MXAN_3495 and 
MXAN_5461) and two (MXAN_0317 and MXAN_6306) acting as 5 and 11 desaturases, 
respectively. This is the first report about heterologous expression and regioselectivity of 
fatty acid desaturases in myxobacteria. 
 
 
The full text of this article is available online at 
http://www3.interscience.wiley.com/journal/122368811/abstract 
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2.7. Biosynthesis of 2-hydroxy and iso-even fatty acids is connected 
to sphingolipid formation in myxobacteria 
Michael W. Ring, Gertrud Schwär and Helge B. Bode* 
ChemBioChem – A European Journal of Chemical Biology 
Vol. 10 (12), pp. 2003-2010, August 17, 2009 
Copyright © 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim 
Abstract 
2-Hydroxy fatty acids can be found in several different organisms including bacteria. In this 
study, we have studied the biosynthesis of 2-hydroxy fatty acids in the myxobacteria 
Myxococcus xanthus and Stigmatella aurantiaca resulting in the identification of a family of 
stereospecific fatty acid -hydroxylases. Although the stereospecificity of the hydroxylases 
differs between these two species, they share a common function in supporting fatty acid 
-oxidation, i.e. the oxidative shortening of fatty acids. Whereas this process takes place 
during normal vegetative growth in S. aurantiaca, this process takes place only under 
developmental conditions in M. xanthus. We could also identify serine palmitoyltransferase 
encoding genes involved in sphingolipid biosynthesis and sphingolipids themselves in both 
myxobacteria and could show that the -hydroxylation reaction is in fact dependent on the 
presence of fatty acids bound to sphingolipids. 
 
 
The full text of this article is available online at 
http://www3.interscience.wiley.com/journal/122477076/abstract 
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2.8. Statements of effort 
ad 2.1 
The author of this thesis performed all GC/MS analyses and their interpretation and 
established a protocol for the preparation of fatty acid picolinyl esters, enabling further 
structural characterization of fatty acids. 
 
ad 2.2 and 2.4 
The author of this thesis performed all lipid extraction as well as the GC/MS analyses and 
their interpretation. Developmental experiments and preparation of cell samples for lipid 
analysis were performed by Gertrud Schwär and the author. 
 
ad 2.3 
All analytical procedures (extraction and fractionation of lipids, analysis by GC/MS and 
HPLC/MS including interpretation), were done by the author of this thesis. Developmental 
experiments and preparation of cell samples were performed by Gertrud Schwär and the 
author. Verena Thiel and Jeroen S. Dickschat conducted the synthetic preparation of 
lipids. 
 
ad 2.5 
The author performed isolation and GC/MS analysis of lipids (including part of the 
developmental experiments and/or cultivations for this purpose) and data interpretation as 
well as the construction of the mutant strains MR1127, MR0412 and MR5582 and the 
heterologous Pseudomonas putida expression strain for MXAN_1127. 
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ad 2.6 
GC/MS and comparative sequence analyses were done by the author of this thesis. The 
author also constructed the P. putida expression strain for MXAN_3495 (desA) and 
designed the primers for the construction of all other expression strains. These strains 
were constructed and cultivated by Edna Bode. Desaturase inactivation mutants were 
made by Gertrud Schwär and Helge B. Bode. 
 
ad 2.7 
This work was conducted completely by the author of this thesis, except for the 
construction of the STIAU_3334 (fahDW) expression strains, which was done by Gertrud 
Schwär. 
Discussion 
3. Discussion 
3.1. Changes in the lipidome during development 
Regarding the overall changes of the lipid profile of M. xanthus during development, four 
aspects have to be mentioned: 
1. the accumulation of ether lipid structures (Chapter 2.3), 
2. the formation and subsequent disappearance of triacylglycerol vesicles 
(Chapter 2.5), and 
3. fatty acid -oxidation (Chapter 2.7). 
Figure 4 shows the main indicators for these changes in the lipidome: The ether lipid-
derived structures iso-15:0 dimethyl acetal (DMA) and 1-O-alkylglycerol (OAG, 
Chapter 2.3), and iso-16:0 as a product of fatty acid -oxidation (Chapter 2.7). The 
observation that these three substances increase during development was the starting 
point for most of the investigations carried out during this study. During sample 
preparation, iso-15:0 OAG is released from the triglyceride analogue TG-1, which is the 
major component in the lipid bodies (Chapter 2.5), so the increase of the OAG also 
indicated that triglyceride-like substances play a role during development. Although the 
amount of the OAG increases steadily, the amounts of TG-1 and the TAGs decrease after 
24 h of development. This discrepancy will be discussed later. 
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Figure 4. Fatty acids and ether lipid-derived structures during development. 
These data were obtained by acidic methanolysis of cell samples and subsequent silylation. 
Relative amounts were calculated with respect to the total peak area of all FAMEs, DMAs and 
OAGs. 
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Figure 5. Structures of both ether lipids from M. xanthus DK1622 identified during 
this study. 
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3.1.1. Ether lipids and triacylglycerols 
The occurrence of ether phospholipids in myxobacteria has been described several 
decades ago (58). There are even hints that mono- and dialkyl phospholipids exist in 
Stigmatella (14), but these findings have never been confirmed by mass spectrometrical 
analysis. Later, a plasmalogen from Myxococcus stipitatus has been structurally 
characterized (122), and the same plasmalogen (VEPE) was purified from M. xanthus 
DK1622 during this study (Chapter 2.3 and Figure 5). Ether phospholipids can be found in 
several other bacterial species (50,130,133). However, the non-polar ether lipid TG-1 
unites two unusual structural features in one molecule: alkyl ether lipid and triglyceride 
analogue. Despite the finding that ether lipids and TAGs are synthesized during 
development, the underlying biochemical pathways have not been elucidated so far. Albeit 
being the standard energy storage form in eukaryotes (89), the occurrence of TAGs in 
bacteria is restricted to certain taxonomic groups (2), but for some bacterial species in 
which TAGs have been found, a wax ester synthase/acyl-CoA:diacylglycerol 
acyltransferase (WS/DGAT) has been identified as the key enzyme for their formation 
(136). Unfortunately, a BlastP query against the genome of M. xanthus gave MXAN_1127 
as a rather weak hit (45 % homology to the WS/DGAT from Acinetobacter sp. ADP-1, with 
13 % gaps), and an inactivation of this gene had no influence on the presence of TAGs 
(Chapter 2.5). An alternative mechanism described for yeast and some plants employs a 
phospholipid:diacylglycerol acyltransferase (PDAT), using phospholipids as acyl donors 
(18), but a BlastP query gave no hit in bacteria at all. 
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Figure 6. Relative amounts of fatty acids and ether lipid-derived structures in 
different cell types of Myxococcus xanthus DK1622. 
Amounts are given in percent. FA, DMA and OAG amounts were measured after 72 h except for 
glycerol sporulation which reaches its final state after 6 h. The term "MCM spores" refers to 
spores obtained by shaking in starvation buffer (109). 
Searches for further acyltransferases revealed the multi-domain protein MXAN_1528, 
whose architecture contains domains with predicted AMP-dependent acyl-CoA synthetase 
and acyltransferase activity, together with an NAD(P)-binding and a phosphopantetheine 
attachment site. Inactivation of this gene caused loss of ether lipids (W. Lorenzen, 
M. W. Ring, H. B. Bode, submitted). Interestingly, homologs of this type of enzyme 
regarding the full length of the amino acid sequence exist only in myxobacteria, as 
determined by BlastP searches. The most closely related enzymes, which belong to 
organisms from the classes of Aquificae and Deltaproteobacteria (in particular Geobacter), 
lack at least the NAD(P)-binding site. 
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However, the complete biosynthesis of ether lipids has not yet been fully clarified. The 
proposed pathway (Chapter 2.3) proceeds in two reduction steps from a PE with an 
iso-15:0 acyl residue at position sn-1 via VEPE to the corresponding 
plasmanylethanolamine (AEPE), which is then transformed into TG-1, probably by 
dephosphorylation and acyl transfer in analogy to TAG biosynthesis (2). This pathway is in 
accordance with the finding that the vinyl ether (represented by iso-15:0 DMA in Figure 6), 
but not the alkyl ether accumulates in spores from shaking cultures (109), indicating that 
certain biochemical reactions of the developmental program are carried out under these 
conditions, but the resulting metabolites are not processed further. Glycerol spores do not 
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Figure 7. Kinetics of iso-15:0 OAG and TG-1 during development. 
Although the amount of iso-15:0 OAG (determined by FAME analysis) increases steadily, the 
amount of the whole lipid TG-1 (determined by high-temperature GC/MS) reaches a maximum 
at 24 h and then declines. 
The OAG content was calculated with respect to the total peak area of all FAMEs, DMAs and 
OAGs. TAG contents were calculated relative to the total lipid mass, by using the peak area of 
the internal standard cetyl palmitate (10 µg per 1 ml of total lipids, as described in Chapter 2.5) 
as a reference. 
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show any accumulation of either ether lipid (Figure 6), therefore, their differences from 
fruiting body spores (48,91) are also accompanied by a different lipid pattern. 
Another highly interesting point is the discrepancy between the recoveries of iso-15:0 OAG 
from whole-cell methanolysis on the one hand and the amount of extractable TG-1 on the 
other hand (Figure 7). Whereas the former increases steadily during development, the 
latter reaches a maximum at about 24 h and then decreases again (Chapter 2.3 and 2.5). 
Thus, there is a transition of the glycerol ether structure from the extractible to the non-
extractible fraction in the time course of development, and this observation leads to the 
assumption that the structure is being attached to the cell envelope by a covalent linkage. 
Posttranslational modification of proteins by attachment of a lipid structure is usually 
encountered in bacterial lipoproteins (111), where a diacylglyceryl moiety is transferred 
from phosphatidylglycerol to the prolipoprotein, more precisely to the sulfhydryl group of 
the cysteine residue at the N-terminus of the upcoming apolipoprotein, resulting in a 
thioether structure (111). However, thioethers are resistant to various hydrolysis conditions 
(104), and as acidic hydrolysis and methanolysis both liberated the OAG, it is unlikely that 
the glycerol ether structure is processed in the same manner in myxobacteria, but in 
general, a transfer of the glycerol ether to a protein or to the lipopolysaccharide or 
peptidoglycan fractions may be an explanation for the above mentioned transition. 
Theoretically, the chemical nature of this attachment may be an ester, e.g. a carboxy ester 
or a dialkyl phosphate or sulfate. For instance, the cell-surface glycoproteins of some 
halophilic archaea contain a diphytanylglyceryl phosphate moiety (56,61). Alkylacylglyceryl 
moieties have also been found in the glycosyl-phosphatidylinositol protein anchors in some 
parasitic protozoa, such as Leishmania major and Trypanosoma cruzi, as well as in 
mammals (85). Other examples for covalent bonds between lipid and amino acid structural 
elements are found in the surfactins from several Bacillus strains (97), where the carboxyl 
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group of the C-terminal amino acid of the peptide chain is esterified with a hydroxyl group 
of the lipid residue, and in the myxochromides from S. aurantiaca DW4/3-1 (139) and 
M. xanthus DK1050 (140), where a fatty acid is linked to the peptide backbone via an 
amide bond. 
Another point, which is still unclear, is the physiological role of ether lipids. TG-1 has been 
shown to restore development in the double mutant DK5624 to a certain extent, with 
fruiting bodies forming preferentially around droplets of TG-1 (Chapter 2.3). Aggregation, 
but not the formation of viable spores, is also restored by TG-2 and TPG. A possible 
reason may be that the sporulation rescue is mediated by iso-15:0, which can be liberated 
from TG-1 by ester hydrolysis, whereas triglyceride-like molecules seem to trigger 
aggregation. This is supported by the observation that a disruption of the above mentioned 
acyltransferase genes and thus, a lack of ether lipids, causes a delay or even a strong 
defect of aggregation in M. xanthus and S. aurantiaca, respectively (W. Lorenzen, 
M. W. Ring, H. B. Bode, submitted). 
In addition, the incorporation of the ether structure into the cell envelope brings up other 
physiological aspects and a comparison with archaea, whose polar lipids constituting the 
cell membrane are based on ether rather than on ester linkages (60). Together with bipolar 
tetraether lipids which span the whole membrane, leading to a mixture of phospholipid bi- 
and monolayers, these ether lipid membranes are important for the extremophilic lifestyle 
of archaea (129) due to their physicochemical properties. There may be an analogy to the 
resistance of myxospores against environmental stress factors such as heat, UV 
irradiation and desiccation (123). Furthermore, it would be interesting to analyze whether 
myxobacterial strains from halophilic (46), acidic or alkaline habitats (101) have a higher 
relative ether lipid content than mesophilic strains, which would also support the 
hypothesis that ether lipids play a role in stress tolerance in myxobacteria. 
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The occurrence of alkyldiacylglycerols has been described for some sharks such as the 
dogfish Squalus acanthias (77), where ether lipids may serve as storage lipids which are 
not metabolizable by predators and where they play a role in the determination of the 
specific buoyancy (78). Whereas the latter mechanism would rather not apply to bacteria, 
the former principle should be considered as one possible role of ether lipids in 
myxobacteria. As the alkyl ether structure is only found in myxospores (Figure 6), whose 
role is to ensure survival of the colony, the transformation of a storage lipid into a non-
metabolizable form together with the incorporation into the cell envelope might result in a 
protection against enzymatic degradation.  
Coming back to development, the increase of ether lipids and the formation of lipid bodies, 
in which TG-1 is a major component (Chapter 2.5), are restricted to cells undergoing 
differentiation into myxospores, at least in the context of development. The differentiation 
into peripheral rods (93) did not show this behavior (see also Figure 6), and this 
observation leads to the hypothesis that lipid body formation is an essential part of the 
early sporulation program. 
However, lipid bodies have been shown to be formed in response to environmental stress 
factors other than starvation as well, such as anaerobiosis and kanamycin treatment 
(Chapter 2.5). This may be interpreted as building up a storage to survive these stress 
conditions, which is also supported by the finding that the intensity of lipid body formation 
correlates with the degree of stress (kanamycin concentration in this case). The 
observation that higher nutrient levels in the starvation agar lead to a higher portion of 
peripheral rods (92) fits into this model, as less starvation would be expected to cause less 
lipid body formation and thus less cells differentiating into spores. In contrast to this, a 
step-down in nutrition lead to lipid body formation in all cells (Chapter 2.5), but this 
experiment was performed in shaking culture, which does not allow normal development 
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requiring cell-to-cell contact (57), as sporulation in starvation buffer under shaking 
conditions (109) does not yield real fruiting body spores either (see also Chapter 2.3 and 
Figure 6). An interesting experiment would be to determine lipid body formation induced by 
a nutritional step-down on solid surfaces and/or in the presence of prey (5). 
It should be mentioned that other bacteria modify the physicochemical properties of their 
membranes under stress conditions, in particular temperature stress, by alteration of the 
fatty acid unsaturation pattern (80,81,88). This type of stress response does not seem to 
occur in M. xanthus (Chapter 2.6). 
Another point of significance is that the fate of cells seems to be sealed when the decision 
pro or contra lipid body formation is made, i.e. the differentiation into spores or peripheral 
rods, respectively. When this decision is caused artificially, e.g. by pretreatment with 
kanamycin, the cell population produces more spores under developmental conditions 
(Chapter 2.5). Cells already containing lipid bodies not only differentiate preferentially into 
spores, but also use their storage to build up a more resistant carbohydrate matrix around 
the fruiting body than non-pretreated cells do. Therefore, a stronger accumulation of lipids 
in response to drastic conditions does not only help the single cell to withstand the stress 
factors, but also serves to improve the protection of the whole colony. 
3.1.2. Fatty acid -oxidation and sphingolipids 
Fatty acid -oxidation is a phenomenon encountered in plants (39), humans (51) and 
bacteria (7,83). Although required for degradation of branched long-chain substrates with 
substituents preventing -oxidation such as phytanic acid (137), an essential role of 
-oxidation in myxobacterial biochemical pathways remains elusive. However, a family of 
fatty acid -hydroxylases has been identified during this study (Chapter 2.7), with close 
sequence relationships to -hydroxylases from other organisms such as yeast, 
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Arabidopsis (87) and humans (1). In the latter, the -hydroxylase is predicted to be 
involved in -oxidation (30), which would fit into the proposed myxobacterial model with 
the -hydroxylation being the first step of -oxidation. A connection to sphingolipid 
metabolism has been shown both for human (1) and yeast (24,37,87) hydroxylases. 
Whereas it is suggested that the fatty acid is hydroxylated prior to sphingolipid formation in 
humans (1), there is evidence that hydroxylation occurs after sphingolipid formation in 
yeast (37). It is quite interesting that these closely related enzymes exert different 
substrate specificities. Considering that the stereochemistry of -hydroxylation differs 
between M. xanthus and S. aurantiaca, it might be that the substrate specificity differs as 
well, which might be an explanation why -hydroxylation is completely shut down in the spt 
mutant strain M. xanthus MR3748, and in S. aurantiaca MR6449, a small amount of 
2-hydroxy fatty acids still can be detected, although both strains are defective in 
sphingolipid biosynthesis (Chapter 2.7). 
When regarding the overall mechanisms of fatty acid -oxidation, it turns out that the plant 
pathway (39) employs a fatty acid -dioxygenase rather than a fatty acid -hydroxylase, 
although the latter type of enzyme has been found in Arabidopsis (87). In contrast, both 
human pathway models (30,51) are based on the formation of a 2-hydroxy fatty acid by the 
hydroxylase. All pathways mentioned have in common that they end up in an aldehyde 
which is oxidized to the fatty acid (summarized in Chapter 2.7). However, iso-16:0 
aldehyde has never been found in the analyzed myxobacterial strains, but this may be due 
to the high reactivity and turnover of aldehydes. 
Like with ether lipids, the physiological role of fatty acid -oxidation remains unclear, and a 
role of -oxidation and/or sphingolipids for development cannot be proposed from the 
obtained results. However, -oxidation in M. xanthus takes place only under 
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developmental conditions, making its product iso-16:0 a biomarker for development 
(see 1.4). In contrast to this, iso-16:0 is present in S. aurantiaca even during vegetative 
growth (7). It is likely that the extent of -oxidation remains at a basal level under 
vegetative conditions in both organisms and that the substantial amount of iso-16:0 in 
S. aurantiaca results from the high quantity of iso-17:0 2-OH in this strain. Further 
experiments regarding fruiting body formation are required to clarify if -oxidation is also 
upregulated during S. aurantiaca development. 
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3.2. Fatty acid biosynthesis 
As mentioned in the introduction (Chapter 1.3), the biosynthesis of fatty acids in bacteria is 
catalyzed by type II fatty acid synthases (73,141), which consist of several dissociable 
proteins (Figure 3). The major fatty acids in myxobacteria are BCFAs (20,138), and to 
understand the biosynthesis of this type of fatty acids, the research during this study 
focused on the formation and further processing of the starter units, mainly isovaleryl-CoA, 
which bring in the methyl group at the -end of the carbon chain. 
3.2.1. Biosynthetic origin of the starter unit 
The formation of the starter units of BCFAs is depicted in Figure 2. An inactivation of the 
genes encoding the subunits of the key enzyme Bkd leads to a decrease, but not a 
complete loss of BCFAs, as isovaleryl-CoA is synthesized from HMG-CoA via an 
alternative pathway (75,76). An alternative route to KIV, which employs the valine 
biosynthesis pathway, has been shown for Staphylococcus carnosus (4), however, the 
subsequent formation of isobutyryl-CoA still requires an active Bkd. In contrast to this, the 
myxobacterial pathway (Chapter 2.4 and Figure 8) consists of some biochemical steps 
corresponding to reverse reactions of the leucine degradation pathway (82). This 
alternative pathway is inactive in the wild-type under vegetative conditions, but it is 
upregulated under developmental conditions and in a Bkd- background (Chapter 2.2). In 
the context of development, the alternative pathway can be interpreted as a compensatory 
mechanism to maintain biosynthesis of iso-fatty acids under leucine-limiting conditions. 
This theory is underlined by the fact that leucine is an essential amino acid for M. xanthus 
(13). Thus, the organism is incapable of leucine de novo biosynthesis, and amino acids 
are preferentially used for the biosynthesis of development-specific proteins (91).  
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Interestingly, the bkd mutant of M. xanthus contains small amounts of iso-16:0 even under 
vegetative conditions. It has been shown that the wild-type is capable of synthesizing 
iso-16:0 from valine (Chapter 2.7), and this is most likely the pathway leading to iso-16:0 in 
the bkd mutant, as the amount of this FA in the bkd mutant increases when feeding 
isobutyrate, but not isovalerate (7). Therefore, a second Bkd activity seems to be 
responsible for the formation of this iso-even fatty acid rather than the alternative pathway 
to isovaleryl-CoA and -oxidation. This possibility is also discussed for 
Staphylococcus aureus (121), where a Bkd- mutant still produces certain amounts of 
BCFAs, which is comparable to myxobacteria. The second Bkd activity might be exerted 
by other 2-oxo acid dehydrogenase complexes such as pyruvate dehydrogenase or 
-ketoglutarate dehydrogenase; for instance, the pyruvate dehydrogenase from 
Bacillus subtilis also accepts branched-chain substrates (94). To investigate this 
hypothesis, the poxB genes MXAN_3654 and MXAN_3857, annotated as pyruvate 
dehydrogenases (35), were inactivated in the bkd mutant of M. xanthus, but feeding with 
labeled valine did not result in significantly different incorporation rates into iso-16:0 (not 
shown). This indicates that either both genes are able to complement each other or none 
of them is responsible for the second Bkd activity. 
3.2.2. Incorporation of the starter unit 
Although the biosynthetic pathways leading to isovaleryl-CoA are mostly clarified in 
M. xanthus (23,75,76)(Chapters 2.2 and 2.4), the corresponding FabH enzyme which is 
responsible for the incorporation of this starter unit into fatty acids has not been identified, 
whereas MXAN_0853 turned out to encode the FabH accepting acetyl-CoA as a substrate, 
as the respective mutant strain DK5614 showed loss of most straight-chain fatty acids 
(Chapter 2.1). A minor amount of straight-chain fatty acids can still be synthesized by 
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utilizing propionyl-CoA or butyryl-CoA, and a different FabH is thought to be involved in 
this biosynthesis. 
Among bacteria, especially Gram-positive bacteria, FabHs with a substrate specificity for 
branched-chain starter units are known from different species (15,40,69,99). However, all 
efforts to generate a BCFA-negative mutant in M. xanthus DK1622 were unsuccessful, 
probably because the candidate genes MXAN_0215 and MXAN_7353 have 
complementary functions, a phenomenon often encountered in myxobacteria due to the 
lineage-specific gene duplications (35,108,113). If both genes are functional and essential 
for BCFA biosynthesis, a double inactivation may be lethal. Heterologous expression of 
myxobacterial FabHs in Pseudomonas putida KT2440 with leucine as the sole carbon 
source did not result in any phenotype (not shown), but this may be due to failure of 
interaction between the Myxococcus FabH and the Pseudomonas fatty acid biosynthesis 
machinery, as a proof of principle experiment with the FabH from Streptomyces coelicolor 
A3(2), whose functionality has been proven (103), did not work either. Furthermore, 
pseudomonads do not require FabH for their fatty acid biosynthesis (114), as shown by 
in vitro experiments with a mixture of the isolated enzymes (44). Thus, it is likely that the 
Pseudomonas ACP is not intended to interact with a FabH enzyme. 
Some reports about Streptomyces strains (71,135) indicate that initiation of fatty acid 
biosynthesis can proceed by FabH-independent mechanisms via formation of a starter unit 
acyl-ACP. When both the starter and the elongation unit are present as acyl-ACP units, 
condensation can be catalyzed by FabB or FabF (Figure 3) instead of FabH, which needs 
an acyl-CoA for the starter unit. The alternative mechanism relies on an acetyl-CoA:ACP 
transacylase (ACAT), transferring the acetyl residue from coenzyme A to an ACP, or on 
acetyl-ACP formation by decarboxylation of malonyl-ACP (74). If, instead of an acetyl 
residue, an isovaleryl residue was linked to the ACP, the model would comply with 
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myxobacterial fatty acid profiles. Although there are some indications that distinct enzymes 
with ACAT activity exist in plants (41), this type of reaction has only been shown to be a 
side activity of other enzymes so far, such as a thiolase from Streptomyces collinus (71) or 
even FabH enzymes themselves (41,74). BlastP queries against the genomes of 
M. xanthus DK1622 and S. aurantiaca DW4/3-1 using the amino acid sequence of the 
S. collinus thiolase (71) gave MXAN_3791 and STIAU_6552 as hits, with 63 and 62 % 
homology, respectively. Both genes are annotated as acetyl-CoA acetyltransferases, so 
one would expect them to catalyze the formation of acetoacetyl-CoA for the mevalonate 
pathway (Chapter 2.4 and Figure 8), which corresponds to the reverse reaction of a 
thiolase. Due to these sequence and functional relationships, it is possible that the 
myxobacterial enzymes also exhibit transacylase activity. 
If myxobacteria use a FabH-independent mechanism for fatty acid biosynthesis, 
inactivation of both fabH candidate genes in M. xanthus DK1622 at the same time would 
not be lethal, but the transacylase gene would still have to be found. Further investigations 
in this field will comprise additional fabH inactivation experiments in both M. xanthus and 
S. aurantiaca, as well as inactivations of the above mentioned candidate genes. 
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3.2.3. The bridge from fatty acid biosynthesis to leucine degradation 
and isoprenoid formation 
Under vegetative conditions, leucine is not only used for protein and BCFA biosynthesis, 
but a significant amount is channeled into the mevalonate pathway (Chapter 2.4), as 
determined by feeding experiments and analysis of the incorporation into the isoprenoid 
geosmin (see also Chapter 1.3 and Figure 8). This connection between primary and 
secondary metabolism provides some metabolic versatility, in particular under 
developmental conditions: Fruiting body formation is not only induced under general 
starvation conditions, but the limitation of one amino acid (79) as well as an overall step-
(mvaK2)mvaDmvk(mvaA)fni(aibR) (gctA) (gctB) (adhZ) mvaS
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Figure 9. Genetic organization of the mevalonate pathway genes in different 
bacterial species. 
The mevalonate pathway gene clusters of M. xanthus DK1622 (35), S. aurantiaca DW4/3-1 
(108), Staphylococcus aureus N315 (65) and Borrelia burgdorferi B31 (31) are depicted. 
Clusters are arranged for comparison regardless of their position in the genome. 
For an explanaition of gene designations see 4.2. Designations which have been assigned 
according to homologies to other genes, but which are not used in the genome annotations, are 
enclosed in brackets. 
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down in nutrition (5) may be sufficient. Under these conditions, which reflect the natural 
circumstances more than the usual laboratory conditions of sudden starvation (43), the 
organism is capable of utilizing acetyl-CoA from the degradation of the remaining nutrients 
to maintain the biosynthesis of isoprenoids and BCFAs in the absence of leucine. 
Evidence has come up from a recent study that not only BCFAs, but also isoprenoids are 
essential for development, as fruiting body formation in a mutant deficient in 
isovaleryl-CoA biosynthesis from both leucine and HMG-CoA was partially restored by the 
addition of mevalonolactone (72). Therefore, it is all the more important that isoprenoid 
biosynthesis is still supported under nutrient limitation and developmental conditions. 
The fact that the genes encoding the enzymes of the alternative pathway for 
isovaleryl-CoA formation constitute an operon with mvaS (see Chapter 2.4 and Figure 9), 
which, in turn, is not transcriptionally linked to mvaA, brings up the hypothesis that the 
primary intended function of MvaS in M. xanthus is the support of this mechanism rather 
than isoprenoid biosynthesis. It has to be mentioned that, in most other bacteria, 
isoprenoids are synthesized by the "non-mevalonate" pathway via 1-deoxy-D-xylulose 
5-phosphate (67). However, in bacteria using the mevalonate pathway (mainly Gram-
positive cocci), mvaA and mvaS are either organized in one operon or are at least located 
in close proximity to each other in the genome (142). On the other hand, mvaA is in an 
operon with the other genes of the mevalonate pathway in M. xanthus and S. aurantiaca 
(Chapter 2.4 and Figure 9). It is suggested that the Gram-positive cocci have acquired 
these genes by horizontal gene transfer (142), which is also thought to be the background 
of M. xanthus secondary metabolite biosynthesis genes (35). If this was the case for the 
mevalonate pathway in M. xanthus as well, these genes would most likely originate from a 
different source due to the different gene organization. 
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3.3. Concluding remarks 
It has been proposed that BCFAs or distinct BCFA species constitute the E-signal (23), but 
this model can be put into question regarding the data obtained during this study. BCFAs 
have to be considered a prerequisite for proper development, but the ability to restore 
development in DK5624 is not restricted to iso-fatty acids, but seems to be exerted by all 
substances acting as exogenous sources for iso-fatty acids or restoring iso-fatty acid 
biosynthesis. This may be an explanation why the formation of viable spores in DK5624 
was not restored by TG-2 and TPG, but by TG-1 (Chapter 2.3), since this lipid contains 
iso-15:0 acyl residues which can be liberated by hydrolysis. However, all three lipids (TG-
1, TG-2 and TPG) restored aggregation, but the underlying mechanism is still elusive. In 
addition, it cannot be ruled out from the presented data that BCFAs or substances derived 
from isovaleryl-CoA have signaling functions. It is still remarkable that a decreased level of 
iso-fatty acids causes developmental defects (Chapter 2.3) and several changes in the 
global expression pattern (Chapter 2.4). 
Besides BCFAs, some SCFA-mediated phenomena have been described, such as the 
involvement of these fatty acids in autolysis (131) and chemotaxis (12). However, models 
which postulate essential roles of these phenomena for development should be 
reexamined regarding the observation that SCFAs are required neither for normal 
vegetative growth nor for developmental functions (Chapter 2.1). An explanation may be 
that the SCFA-deficient mutant strain uses alternative mechanisms to maintain proper 
developmental functions in the absence of SCFAs, like the bkd mutant produces 
isovaleryl-CoA via the alternative pathway (Chapters 2.2 and 2.4). 
In summary, the present study gave many insights into the lipidomes of Myxococcus 
xanthus and Stigmatella aurantiaca, with the focus on lipids which are not ubiquitous 
among bacteria. These include ether lipids (Chapter 2.3), triacylglycerols (Chapter 2.5) 
49 
Discussion 
50 
and sphingolipids (Chapter 2.7), and all three lipid classes are influenced by the 
developmental program of myxobacteria. Further investigations will have to concentrate on 
the roles of these lipids for proper function of the complex regulatory network directing the 
myxobacterial life cycle, and on the enzymes involved in lipid modification and 
transformation and in lipid-mediated developmental processes. 
References 
4. Appendix 
4.1. Abbreviations 
ACAT acetyl-CoA:acyl-carrier protein transacylase 
ACP acyl-carrier protein 
AEPE alkyl ether phosphatidylethanolamine, in this context: 
1-O-(13-methyltetradecyl)-2-O-(13-methyltetradecanoyl)-
glycero-3-phosphatidylethanolamine 
BCFA branched-chain fatty acid 
CoA coenzyme A 
DMA dimethyl acetal 
EC enzyme commission 
FA fatty acid 
FAME fatty acid methyl ester 
GC gas chromatography 
HMG-CoA 3-hydroxy-3-methylglutaryl-CoA 
KAS -ketoacyl-ACP synthase 
KIC -ketoisocaproate syn. 4-methyl-2-oxobutanoate 
KIV -ketoisovalerate syn. 3-methyl-2-oxopropanoate 
KMV –keto--methylvalerate syn. 3-methyl-2-oxobutanoate 
MS mass spectrometry 
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OAG 1-O-alkylglycerol 
PE phosphatidylethanolamine 
SCFA straight-chain fatty acid 
TAG triacylglycerol 
TG-1 1,2-di-(13-methyltetradecanoyl)-3-(13-methyltetradecyl)glycerol
TG-2 1,2-di-(hexadecanoyl)-3-(13-methyltetradecyl)-glycerol 
TPG glycerol tripalmitate 
UV ultraviolet 
VEPE vinyl ether phosphatidylethanolamine, in this context: 
1-O-(13-methyl-1-Z-tetradecenyl)-2-O-(13-methyl-
tetradecanoyl)-glycero-3-phosphatidylethanolamine 
 
4.2. Gene and locus designations 
Designation Encoded protein EC number 
adhZ alcohol dehydrogenase, Zn-binding 1.1.1.1 
aibR alternative isovaleryl-CoA biosynthesis regulator  
bkd branched-chain keto acid dehydrogenase 1.2.4.4 and 
2.3.1.168 
fabB or fabF 3-oxoacyl-ACP synthase (KAS) I or II 2.3.1.41 or 
2.3.1.179 
fabG 3-oxoacyl-ACP reductase 1.1.1.100 
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Designation Encoded protein EC number 
fabH 3-oxoacyl-ACP synthase III 2.3.1.180 
fabI, fabK or fabL enoyl-ACP reductase 1.3.1.- 
fabZ or fabA 3-hydroxyacyl-ACP dehydratase 4.2.1.- 
fni isopentenyl-diphosphate -isomerase 5.3.3.2 
gctA and gctB glutaconyl-CoA transferase subunits A and B  
ilvE branched-chain amino acid aminotransferase 2.6.1.42 
liuA isovaleryl-CoA dehydrogenase 1.3.99.10 
liuB 3-methylcrotonyl-CoA carboxylase 
syn. 3,3-dimethylacrylyl-CoA carboxylase 
6.4.1.4 
liuC 3-methylglutaconyl-CoA hydratase 4.2.1.18 
mvaA HMG-CoA reductase 1.1.1.34 
mvaD diphosphomevalonate decarboxylase 4.1.1.33 
mvaK1 or mvk mevalonate kinase 2.7.1.36 
mvaK2 phosphomevalonate kinase 2.7.4.2 
mvaS HMG-CoA synthase 2.3.3.10 
poxB pyruvate dehydrogenase 1.2.2.2 
spt serine palmitoyltransferase 2.3.1.50 
ypgA carotenoid biosynthesis protein  
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